Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)
CAPS Rating:
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
Recs
Lots of vry expensive marketing, but little to show on the bottom line with lots of cash burn